ArticleJournal of inflammation research2025
Predictive Value of Advanced Lung Cancer Inflammation Index and Development of a Nomogram for Prognosis in Patients with Cervical Cancer Treated with Radiotherapy.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Neighborhood deprivation and lung cancer incidence and mortality in patients with asthma: a nationwide cohort study in Sweden, 1997-2018.Respiratory research · 2026Article
- Platelet-to-high-density lipoprotein ratio predicts postoperative overall survival in hepatocellular carcinoma: a retrospective cohort study.World journal of surgical oncology · 2026Article
- Development and Validation of a Nomogram Based on Advanced Lung Cancer Inflammation Index for Predicting Overall Survival in Non-Surgical Esophageal Squamous Cell Carcinoma.Journal of inflammation research · 2026Article
- Prognostic value of combining nutritional inflammatory index trajectories and tumor characteristics in cervical cancer.BMC women's health · 2025Article
- Comment on "Predictive Value of Advanced Lung Cancer Inflammation Index and Development of a Nomogram for Prognosis in Patients with Cervical Cancer Treated with Radiotherapy" [Response to Letter].Journal of inflammation research · 2025Article
- Comment on "Predictive Value of Advanced Lung Cancer Inflammation Index and Development of a Nomogram for Prognosis in Patients with Cervical Cancer Treated with Radiotherapy" [Letter].Journal of inflammation research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: As an assessment tool of nutritional status and inflammation, the advanced lung cancer inflammation index (ALI) is associated with survival in various cancers. We aimed to investigate the association between the ALI's prognostic value and survival time in patients with the stage IIB-III cervical cancer treated with radiotherapy. Patients and Methods: We retrospectively screened patients diagnosed with cervical cancer and underwent radiotherapy in a single institution between September 2013 to September 2015. The ALI was calculated as body mass index * serum albumin/neutrophil-to-lymphocyte ratio. The cut-off value of ALI was determined by the receiver operating characteristic (ROC) curves. Overall survival (OS) and progression-free survival (PFS) were evaluated using the Kaplan-Meier method and Cox proportional hazards models. A nomogram was developed using prognostic factors based on multivariate analyses. Results: A total of 178 patients with cervical cancer were included. The cutoff value of ALI was set at 310.6 by ROC analyses. Kaplan Meier survival curves indicated that patients with low ALI had a significantly poorer OS (log-rank P<0.001) and PFS (log-rank P=0.0056) than those with high ALI. The association between ALI and OS was significant in the patients with obese/overweight and low/normal weight. The Cox regression analysis indicated that patients with low ALI were associated with a decreased OS (Hazard Ratio (HR) = 2.56, 95% Confidence Intervals (CI), 1.35-4.83; P= 0.004) and PFS (HR = 1.83; 95% CI, 1.06-3.17; P = 0.031). The nomogram on OS was created based on ALI with C-index of 0.81. Patients with high nomogram points had worse OS than those with low nomogram points (log rank P<0.0001). Conclusion: Pretreatment ALI is an independent negative prognostic factor in patients with cervical cancer treated with radiotherapy. The ALI based nomogram can help to identify patients who may have unfavorable outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.